Peringkat dalam Saham
#40970
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney... Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.
Kapitalisasi Pasar
$56.86K
Perubahan (1 tahun)
-52.28%
Perdagangan Verici Dx plc (VRCI)
Harga VRCI dengan kapitalisasi pasar B
Kapitalisasi pasar dari Verici Dx plc(VRCI)
Kapitalisasi Pasar: $56.86K
Per August 2026, Verici Dx plc memiliki kapitalisasi pasar sebesar $56.86K. Ini menjadikan Verici Dx plc sebagai perusahaan 40970th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Verici Dx plc dari 2020 hingga 2026
VRCI dibandingkan dengan 5 teratas stocks paling populer
| Harga VRCI |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.442T
|
+9,571,203,302.24%
|
|
|
|
|
$4.463T
|
+7,849,529,404.55%
|
|
|
|
|
$4.176T
|
+7,344,463,751.88%
|
|
|
|
|
$3.680T
|
+6,471,201,334.90%
|
|
|
|
|
$2.869T
|
+5,045,838,655.01%
|
